Table 1.
Characteristics of MN patients
| Diagnosis | Cases |
|---|---|
| AML and related precursor neoplasms | 231 |
| AML with recurrent genetic abnormalities | 83 |
| AML with RUNX1-RUNX1T1 | 7 |
| AML with CBFB-MYH11 | 10 |
| Acute promyelocytic leukemia with PML-RARA | 42 |
| AML with mutated NPM1 | 10 |
| AML with biallelic mutation of CEBPA | 10 |
| AML with mutated RUNX1 | 4 |
| AML with myelodysplasia-related changes | 5 |
| Therapy-related AML | 3 |
| AML, NOS | 140 |
| AML without maturation | 6 |
| AML with maturation | 52 |
| Acute myelomonocytic leukemia | 41 |
| Acute monoblastic and monocytic leukemia | 41 |
| Myeloproliferative neoplasms | 77 |
| CML | 47 |
| Primary myelofibrosis | 30 |
| MDS | 63 |
| Myelodysplastic/myeloproliferative neoplasm | 17 |
| Chronic myelomonocytic leukemia | 10 |
| Myelodysplastic/myeloproliferative neoplasm, unclassifiable | 7 |
| Total MN | 388 |